Skip to main content
Clinical Trials/NCT00656929
NCT00656929CompletedNot Applicable

A Randomized Controlled Trial of Vitamin D3 Supplementation for the Prevention of Viral Upper Respiratory Tract Infections

Winthrop University Hospital0 sites167 target enrollmentStarted: December 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
167
Primary Endpoint
To see whether vitamin D3 supplementation during the winter prevents viral URI.

Study Overview

Brief Summary

Background: Vitamin D has been shown to be an important immune system regulator. Vitamin D insufficiency during the winter may cause increased susceptibility to infections, particularly viral upper respiratory tract infections (URIs).

Objective: To determine whether vitamin D supplementation during the winter season prevents or decreases URI symptoms in adults.

Methods: A randomized, double-blind, placebo-controlled trial was conducted in 162 adults. Participants were randomized to receive vitamin D3 50 mcg (2000 IU) daily or matching placebo for 12 weeks from December 2006 to March 2007. A biweekly questionnaire was used to record the incidence and severity of URI symptoms

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • ambulatory adult age 18-80 and stable medical condition with no change in medications for 6 months prior to study entry.

Exclusion Criteria

  • morbid obesity (body mass index > 35 kg/m2)
  • current tobacco use
  • history of hypercalcemia, nephrolithiasis or sarcoidosis
  • pregnancy
  • recent hospitalization
  • current liver or kidney disorders, malignancy and malabsorption
  • use of immunosuppressants or medications that interfere with vitamin D metabolism such as phenytoin and carbamazepine.

Outcomes

Primary Outcomes

To see whether vitamin D3 supplementation during the winter prevents viral URI.

Time Frame: 3 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Similar Trials